ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.

News Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Equities

300357

CNE100001R58

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
24.05 ^CNY	-0.21%		+5.76%	-17.07%

04-18	Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023	23-06-29	CI
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it has received CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	23-06-18	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022	23-05-19	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	23-04-21	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it expects to receive CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. and other investors	23-04-19	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Executive Appointments	22-12-29	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-20	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Implements Final Profit Distribution Plan A shares for 2021, Payable on June 16, 2022	22-06-10	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-06-01	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-27	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-15	CI
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Cash Dividend for 2020, Payable on 01 June 2021	21-05-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Equities

300357

CNE100001R58

Summary

Filters